- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Eslicarbazepine acetate
Total 3955 results
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Terminated
-
Bial - Portela C S.A.Completed
-
SunovionCompletedEpilepsyUnited States, Bulgaria, Czech Republic, Serbia, Ukraine
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.SunovionCompletedPartial EpilepsyUnited States, Argentina, Germany, France, Belgium, Canada, Italy, Poland, Greece, Brazil, Cyprus
-
Bial - Portela C S.A.CompletedEpilepsySpain, Bulgaria, Austria, Croatia, Czechia, France, Germany, Poland, Portugal, Romania
-
Centre Hospitalier Saint Joseph Saint Luc de LyonUnknownEpilepsy | Aging | Epilepsy; Seizure | Aging DisorderFrance
-
Bial - Portela C S.A.CompletedEfficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial SeizuresRefractory Partial EpilepsyPortugal
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Eisai Inc.CompletedPartial Onset SeizuresFrance, United Kingdom, Germany, Denmark, Czech Republic, Norway, Sweden, Ireland
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.CompletedPartial Epilepsy in Children and AdolescentsUnited Kingdom, Spain, Serbia, Italy, Austria, Bosnia and Herzegovina, Croatia, Czechia, France, Germany, Hungary, Malaysia, Moldova, Republic of, Philippines, Poland, Portugal, Romania, Russian Federation, Slovakia, Taiwan, Ukr...
-
Bial - Portela C S.A.CompletedPartial EpilepsyNetherlands, Poland, Italy, Russian Federation, Ukraine
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.TerminatedPainful Diabetic NeuropathyPortugal
-
Bial - Portela C S.A.CompletedEfficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial EpilepsyPartial EpilepsyPortugal
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Terminated
-
SunovionCompletedEpilepsy With Partial On-set SeizuresUnited States, Canada
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.CompletedEpilepsyUnited States
-
Karolinska InstitutetCompleted
-
NovartisCompleted
-
SunovionCompletedEpilepsy With Simple or Complex Partial Onset SeizuresUnited States, Canada
-
NovartisCompletedOpen Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I DisorderBipolar DisorderAustria, Canada, Czech Republic, Germany, Peru, Russian Federation, Slovakia, South Africa, Ukraine, Venezuela, United States, Colombia, Guatemala
-
NovartisCompleted
-
NovartisCompleted
-
Novartis PharmaceuticalsCompletedBipolar DisorderUnited States, France, Russian Federation
-
Bial - Portela C S.A.CompletedPainful Diabetic Neuropathy
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed
-
Bial - Portela C S.A.Completed